Development and analytic validation of an electron ionization gas chromatography/mass spectrometry (EI-GC/MS) method for the measurement of 3-bromotyrosine in canine serum

Sattasathuchana, Panpicha; Berghoff, Nora; Grützner, Niels; Thengchaisri, Naris; Rangachari, Venkat R; Suchodolski, Jan S; Steiner, Jörg M (2016). Development and analytic validation of an electron ionization gas chromatography/mass spectrometry (EI-GC/MS) method for the measurement of 3-bromotyrosine in canine serum. Veterinary clinical pathology, 45(3), pp. 515-523. Wiley-Blackwell 10.1111/vcp.12373

[img] Text
vcp12373.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (289kB) | Request a copy

BACKGROUND The activation of eosinophils causes the release of eosinophil peroxidase and subsequent production of 3-bromotyrosine (3-BrY), a stable byproduct. In people, 3-BrY is used as a biomarker for eosinophil activation. The method for measuring 3-BrY concentrations in biologic samples from dogs has not previously been described. OBJECTIVES The objective of this study was to develop and analytically validate an electron ionization gas chromatography/mass spectrometry (EI-GC/MS) method for the measurement of 3-BrY in canine serum samples. METHODS Pooled canine serum samples were utilized to validate the assay. Serum samples from healthy control dogs (n = 41) were used to evaluate 3-BrY concentrations and establish a reference interval. RESULTS The analytic validation revealed that the limit of blank and limit of detection were 0.33 and 0.63 μmol/L, respectively. The coefficients of variation for precision and reproducibility for 3-BrY were < 13.9% and < 11.0%, respectively. The means ± SD of observed-to-expected ratios for linearity and accuracy were 109.6 ± 17.2% and 98.7 ± 11.3%, respectively. The reference interval was determined as ≤ 1.12 μmol/L (median [range]: ≤ 0.63 μmol/L [≤ 0.63-1.13]). CONCLUSIONS The EI-GC/MS assay described here for the measurement of 3-BrY in canine serum samples was precise, reproducible, linear, and accurate. Further studies are underway to determine the diagnostic utilities in canine patients with eosinophilic diseases.

Item Type:

Journal Article (Original Article)

Division/Institute:

05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV) > Swine Clinic
05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV)

UniBE Contributor:

Grützner, Niels

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0275-6382

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Daniela Fasel

Date Deposited:

15 Feb 2017 16:03

Last Modified:

17 Feb 2017 18:10

Publisher DOI:

10.1111/vcp.12373

PubMed ID:

27428603

Uncontrolled Keywords:

3-bromotyrosine; canine; eosinophil activation; eosinophil peroxidase; serum

BORIS DOI:

10.7892/boris.91583

URI:

https://boris.unibe.ch/id/eprint/91583

Actions (login required)

Edit item Edit item
Provide Feedback